Related Experiment Video
Updated: May 28, 2026
09:45
Radiosensitivity of Cancer Stem Cells in Lung Cancer Cell Lines
Published on: August 21, 2019
Differentiation pathways in carcinogenesis and in chemo- and radioresistance
1Department of Clinical and Molecular Pathology, Palacky University , Czech Republic.
Neoplasma
|October 25, 2011
Summary
Cancer stem cells (CSCs) and embryonic stem cells (ESCs) share self-renewal and differentiation abilities. Key signaling pathways influence cancer development and resistance to cancer therapies.
Area of Science:
- Stem cell biology
- Cancer research
- Molecular oncology
Background:
- Cancer stem cells (CSCs) exhibit properties similar to embryonic stem cells (ESCs), including self-renewal and differentiation.
- Signaling pathways like Wnt, Notch, and Hedgehog are crucial for these stem cell processes.
- These pathways are implicated in the development of chemo- and radioresistance in cancer.
Purpose of the Study:
- To review the role of three key differentiation pathways in carcinogenesis.
- To examine the influence of these pathways on chemo- and radioresistance in ESCs and CSCs.
Main Methods:
- Literature review of differentiation pathways.
- Analysis of signaling pathways in ESCs and CSCs.
- Focus on Wnt, Notch, and Hedgehog pathways.
Main Results:
- Identified shared features between CSCs and ESCs.
- Highlighted the involvement of specific signaling pathways in stem cell functions.
- Demonstrated the link between these pathways and therapeutic resistance.
Conclusions:
- Differentiation pathways critically influence cancer initiation and progression.
- Targeting these pathways may overcome chemo- and radioresistance in cancers with CSCs.
- Understanding these mechanisms is vital for developing novel cancer treatments.
Related Concept Videos
02:56Treatment Resistant Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
02:53Adaptive Mechanisms in Cancer Cells
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
02:53Adaptive Mechanisms in Cancer Cells
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
02:40Cancer Stem Cells and Tumor Maintenance
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
02:50Combination Therapies and Personalized Medicine
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
01:25Mutagenicity and Carcinogenicity
Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...